Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Implications from autopsy studies of latent prostate cancer

Nature Reviews Urology volume 17, pages 428–429 (2020)Cite this article

Subjects

Autopsy studies of latent prostate cancer provide important information for understanding the disease and, crucially, for addressing overdiagnosis. Further autopsy studies with standardized methods are needed to drive progress in this field, and studying the differences between latent and clinically significant prostate cancer might be a promising direction for future research.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Grossman, D. C. et al. Screening for prostate cancer: US Preventive Services Task Force Recommendation Statement. JAMA 319, 1901–1913 (2018).

    Article  Google Scholar 

  2. Rebbeck, T. R. & Haas, G. P. Temporal trends and racial disparities in global prostate cancer prevalence. Can. J. Urol. 21, 7496–7506 (2014).

    PubMed  PubMed Central  Google Scholar 

  3. Bell, K. J., Del Mar, C., Wright, G., Dickinson, J. & Glasziou, P. Prevalence of incidental prostate cancer: a systematic review of autopsy studies. Int. J. Cancer 137, 1749–1757 (2015).

    Article  CAS  Google Scholar 

  4. Jahn, J. L., Giovannucci, E. L. & Stampfer, M. J. The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the prostate-specific antigen-era. Int. J. Cancer. 137, 2795–2802 (2015).

    Article  CAS  Google Scholar 

  5. Matoso, A. & Epstein, J. I. Defining clinically significant prostate cancer on the basis of pathological findings. Histopathology 74, 135–145 (2019).

    Article  Google Scholar 

  6. Haas, G. P. et al. Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence. J. Natl Cancer Inst. 99, 1484–1489 (2007).

    Article  Google Scholar 

  7. Zlotta, A. R. et al. Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men. J. Natl Cancer Inst. 105, 1050–1058 (2013).

    Article  CAS  Google Scholar 

  8. Kornberg, Z. et al. Genomic prostate score, PI-RADS™ version 2 and progression in men with prostate cancer on active surveillance. J. Urol. 201, 300–307 (2019).

    Article  Google Scholar 

  9. McNeal, J. E. Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. Hum. Pathol. 23, 258–266 (1992).

    Article  CAS  Google Scholar 

  10. Breslow, N. et al. Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France. Int. J. Cancer 20, 680–688 (1977).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China

    Yuliang Chen & Weigang Yan

Authors
  1. Yuliang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Weigang Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Weigang Yan.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, Y., Yan, W. Implications from autopsy studies of latent prostate cancer. Nat Rev Urol 17, 428–429 (2020). https://doi.org/10.1038/s41585-020-0327-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41585-020-0327-7

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing